Skip to main content
DNTH
NASDAQ Life Sciences

Dianthus Posts $46.6M Q3 Loss, Touts 75% CIDP Response Rate and $1.2B Cash Into 2030

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$85.81
Mkt Cap
$4.799B
52W Low
$32.42
52W High
$117.875
52W Position info
165% above low
Off High info
27% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

DNTH has more than doubled off its 52-week low of $32.42 on elevated volume (2.0× avg).

Summary

Dianthus reported a $46.6M net loss for Q3 2026, or $0.81 per share, versus $36.8M a year ago, with R&D spending up to $45.6M on claseprubart Phase 2/3 costs and early pipeline work. The clinical update is the real story: a 75% response rate in the interim responder analysis of the first 40 CAPTIVATE Part A patients in CIDP, above the 50% target set from prior aC1s precedent, with no related serious infections or drug-induced lupus. CAPTIVATE Part A enrollment is now projected under 200 patients to randomize 128 responders into Part B, with Part A top-line by YE'27 and Part B by YE'28. The Phase 2 MoMeNtum MMN trial beat its 36-patient enrollment target and will report top-line data on 46 patients in December 2026, ahead of a planned Phase 3 in 2027. Roughly $1.2B in cash funds operations into 2030, so there is no near-term financing need despite the $500M ATM shelf filed in September. December's MoMeNtum readout is the next binary event for the stock.

At the time of this announcement, DNTH was trading at $85.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.8B. The 52-week trading range was $32.42 to $117.88. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

DNTH - Latest Insights

DNTH
Nov 04, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $85.81
Real-time Price: $84.08 info
Change: -$1.73 (-2%) info
Market Cap: $4.761B info
DNTH
Aug 07, 2026, 6:30 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $108.92
Real-time Price: $84.08 info
Change: -$24.84 (-23%) info
Market Cap: $4.761B info
DNTH
Aug 07, 2026, 4:18 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $108.92
Real-time Price: $84.08 info
Change: -$24.84 (-23%) info
Market Cap: $4.761B info
DNTH
Aug 04, 2026, 4:08 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $111.00
Real-time Price: $84.08 info
Change: -$26.92 (-24%) info
Market Cap: $4.761B info
DNTH
Aug 04, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $111.00
Real-time Price: $84.08 info
Change: -$26.92 (-24%) info
Market Cap: $4.761B info